Katie Brighton
Scientific Copywriter
Katie joined Technology Networks in January 2022 after completing a bachelor’s degree in biochemistry and a master’s by research degree in molecular and cellular biology, both at the University of Leeds. They loved the breadth of scientific content covered in their undergraduate studies and wanted to share their passion for research through science communication. As a scientific copywriter, Katie assembles newsletters, writes promotional webinar copy, supports the publication’s in-house writers and produces scientific content.
Latest Content
News
Memories “Lost” During Sleep Deprivation Can Be Recalled
New research from the University of Groningen, published in Current Biology, has illustrated that memories made while sleep-deprived aren’t lost for good, they’re just more difficult to recall.
Industry Insight
The Road to a Sustainable Precision Health Ecosystem in Taiwan
To find out more about the Taiwan Precision Medicine Initiative and its aim to implement a sustainable precision health ecosystem in Taiwan, we spoke to Dr. Pui-Yan Kwok, leader of the initiative.
Industry Insight
New Levels of Sensitivity in LC-MS
The development of the 7500 LC-MS system from SCIEX is bringing new levels of analytical sensitivity to researchers. To find out more about the system and the applications that could benefit, we spoke to Jack Steed, a technical specialist from SCIEX.
Industry Insight
Translating Data Into Clinical Insights With Bioinformatics
In this interview, we find out about how bioinformatics can help researchers extract more information from complex datasets and how this contributes to a holistic approach to healthcare.
Industry Insight
Addressing RNA Research Challenges
In this interview, we hear from Dr. Eliza Small about the current challenges facing RNA therapeutic development and how these challenges can be overcome.
Article
Who Was the Father of Modern Plastic Surgery?
In this article, we go back in history to find out more about Harold Gillies – the father of modern plastic surgeries – and the techniques he pioneered.
Industry Insight
A New Approach to T-Cell Therapy
In this interview with Bryan Kobel, CEO of TC Biopharm, we find out about gamma-delta T-cell therapy, including how it works, its applications and how TC Biopharm developed its pioneering gamma-delta treatment for acute myeloid leukemia.
Industry Insight
Exploring Flow Electroporation for Cell Engineering
Technology Networks spoke to Dr. Cenk Sumen, chief scientific officer of MaxCyte, about their pioneering cell engineering platform.
Industry Insight
Developing Therapeutics To Combat ALS
In this interview, we speak to Alon Ben-Noon, CEO and co-founder of Neurosense Therapeutics to hear about the impact their drug development strategy is having on the ALS field.
Industry Insight
Automation in the Lab of the Future
In a recent interview with Technology Networks, Mathew Keegan discusses how automation is already enhancing the lab experience, the challenges it faces and where it may head in the future.
Advertisement
